Literature DB >> 23271300

Diagnosis and treatment of clear cell hidradenocarcinoma of the scalp.

Kai Shu1, Qungen Xiao1, Fabian Büchele2, Suojun Zhang1, Wei Jiang3, Ting Lei1.   

Abstract

Clear cell hidradenocarcinoma (CCH) is an exceedingly rare and highly malignant tumor of the eccrine sweat glands. Its treatment is extremely difficult due to the characteristically aggressive clinical course including repeated local recurrence and uncontrollable distal metastasis coming along with a very poor prognosis. Most published case studies recommend a wide surgical excision followed by adjuvant conservative therapy, which is generally considered to be the standard treatment. Two cases of nodular CCH of the scalp either presenting as a singular primary lesion or at an already metastatic stage were analyzed retrospectively. Wide local excision of the tumor couldn't prevent the primary carcinoma from recurring and metastasizing. Both cases received various therapies but the results were unsatisfactory. Although most authors have recommended that early wide surgical excision of the tumor is a feasible therapeutic measurement, our results raise doubts on the efficacy of this treatment strategy. As alternative approaches (i.e. chemotherapy, radiotherapy) are similarly controversial, further studies and a wide exchange of clinical experiences are crucial.

Entities:  

Mesh:

Year:  2012        PMID: 23271300     DOI: 10.1007/s11596-012-1061-z

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  28 in total

1.  Metastatic hidradenocarcinoma with demonstration of Her-2/neu gene amplification by fluorescence in situ hybridization: potential treatment implications.

Authors:  Jason W Nash; Terry L Barrett; Merrill Kies; Merrick I Ross; Nour Sneige; A Hafeez Diwan; Alexander J F Lazar
Journal:  J Cutan Pathol       Date:  2007-01       Impact factor: 1.587

Review 2.  Metastatic malignant acrospiroma of the hand.

Authors:  I Görtler; H Köppl; G B Stark; R E Horch
Journal:  Eur J Surg Oncol       Date:  2001-06       Impact factor: 4.424

3.  Chemosurgical report: a nongeometric approach to wound closure following Mohs surgery.

Authors:  L M Dzubow
Journal:  J Dermatol Surg Oncol       Date:  1986-04

Review 4.  Metastatic clear-cell hidradenocarcinoma of the vulva.

Authors:  M J Messing; M S Richardson; M T Smith; L King; D G Gallup
Journal:  Gynecol Oncol       Date:  1993-02       Impact factor: 5.482

5.  Malignant clear-cell hidradenoma.

Authors:  L F Lopez-Burbano; G A Cimorra; E Gonzalez-Peirona; J Alfaro
Journal:  Plast Reconstr Surg       Date:  1987-08       Impact factor: 4.730

6.  Lymphatic mapping and sentinel lymph node biopsy in the detection of early metastasis from sweat gland carcinoma.

Authors:  Paul N Bogner; Douglas R Fullen; Lori Lowe; Augusto Paulino; J Sybil Biermann; Vernon K Sondak; Lyndon D Su
Journal:  Cancer       Date:  2003-05-01       Impact factor: 6.860

7.  Eccrine adenocarcinoma. A clinicopathologic study of 35 cases.

Authors:  A H Mehregan; K Hashimoto; H Rahbari
Journal:  Arch Dermatol       Date:  1983-02

Review 8.  Nodular hidradenocarcinoma on the scalp of a young woman: case report and review of literature.

Authors:  Masayoshi Ohta; Michiaki Hiramoto; Miki Fujii; Takeshi Togo
Journal:  Dermatol Surg       Date:  2004-09       Impact factor: 3.398

9.  Clear cell carcinoma of the skin. A variant of the squamous cell carcinoma that simulates sebaceous carcinoma.

Authors:  T Kuo
Journal:  Am J Surg Pathol       Date:  1980-12       Impact factor: 6.394

10.  Clear cell eccrine carcinomas of the skin. A clinicopathologic study of nine patients.

Authors:  T Y Wong; S Suster; T Nogita; L M Duncan; R G Dickersin; M C Mihm
Journal:  Cancer       Date:  1994-03-15       Impact factor: 6.860

View more
  1 in total

1.  An Unusual Case of Lower Extremity Clear Cell Hidradenocarcinoma.

Authors:  Marc Rafols; Odille Mejia; Kei Shing Oh; Blake Bendixen; Irving Jorge; Sumana Narayanan
Journal:  Case Rep Surg       Date:  2020-04-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.